Skip to main content

Edwards Lifesciences Corp ownership: holders and insider trading

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.11−0.04%Close 16 Nov 2026 · Market value $61.54B

As filed, its directors and officers own 0.3% of the shares (proxy statement, 31 Jan 2026); 1,320 institutional managers reported holding 91.0% at 30 Jun 2026. Over the last twelve months, insiders sold $34.06M of shares on the open market, $20.87M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
The Vanguard GroupHolder70.0M12.16%*Form 13F30 Jun 2026
BlackRock, Inc.Holder58.8M10.21%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder43.5M7.54%Schedule 13G31 Mar 2026
State StreetInstitution26.3M4.57%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution22.8M3.96%*Form 13F30 Jun 2026
Wellington ManagementInstitution16.8M2.92%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution15.4M2.68%*Form 13F30 Jun 2026
BNYInstitution14.1M2.45%*Form 13F30 Jun 2026
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainInstitution13.0M2.26%*Form 13F30 Jun 2026
Ninety One UK LtdInstitution12.3M2.14%*Form 13F30 Jun 2026
Aristotle Capital Management, LLCInstitution8.7M1.51%*Form 13F30 Jun 2026
Alliancebernstein L.p.Institution8.7M1.50%*Form 13F30 Jun 2026
Fidelity (FMR)Institution8.4M1.47%*Form 13F30 Jun 2026
Norges BankInstitution8.4M1.45%*Form 13F30 Jun 2026
UBSInstitution7.8M1.36%*Form 13F30 Jun 2026
Brown Advisory IncInstitution7.4M1.28%*Form 13F30 Jun 2026
Bank of AmericaInstitution6.7M1.16%*Form 13F30 Jun 2026
Artisan Partners Limited PartnershipInstitution6.6M1.15%*Form 13F30 Jun 2026
Morgan StanleyInstitution6.3M1.10%*Form 13F30 Jun 2026
Arrowstreet Capital, Limited PartnershipInstitution5.7M0.99%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Dahl Andrew M. · SVP, Corporate Controller13 Nov 2026Shares withheld for tax−101$105.80$10.69K
Lippis Daniel J. · CVP, TAVR10 Nov 2026Option exercise+619$72.68$44.99K
Lippis Daniel J. · CVP, TAVR10 Nov 2026Open-market sale (10b5-1 plan)−619$104.25$64.53K
Zovighian Bernard J · CEO · Director9 Nov 2026Option exercise+23.1K$72.68$1.68M
Zovighian Bernard J · CEO · Director9 Nov 2026Open-market sale (10b5-1 plan)−9.2K$103.39$949.5K
Zovighian Bernard J · CEO · Director9 Nov 2026Open-market sale (10b5-1 plan)−13.9K$102.78$1.43M
BOBO DONALD E JR · CVP,Strategy/Corp Development9 Nov 2026Option exercise+48.9K$72.68$3.55M
BOBO DONALD E JR · CVP,Strategy/Corp Development9 Nov 2026Open-market sale (10b5-1 plan)−48.9K$103.05$5.04M
Lippis Daniel J. · CVP, TAVR8 Oct 2026Option exercise+619$72.68$44.99K
Lippis Daniel J. · CVP, TAVR8 Oct 2026Open-market sale (10b5-1 plan)−619$85.65$53.02K
Markowitz Wayne · CVP, JAPAC14 Sep 2026Shares withheld for tax−568$84.37$47.92K
Dahl Andrew M. · SVP, Corporate Controller13 Sep 2026Shares withheld for tax−253$84.37$21.35K
Markowitz Wayne · CVP, JAPAC11 Sep 2026Shares withheld for tax−355$86.77$30.80K
Chopra Daveen · CVP, TMTT, Surgical & IHFM11 Sep 2026Shares withheld for tax−398$86.77$34.53K
Lippis Daniel J. · CVP, TAVR11 Sep 2026Option exercise+619$72.68$44.99K
Lippis Daniel J. · CVP, TAVR11 Sep 2026Open-market sale (10b5-1 plan)−619$87.51$54.17K
Dahl Andrew M. · SVP, Corporate Controller31 Aug 2026Open-market sale−544$91.06$49.54K
Bruls Annette · CVP, EMEACLA28 Aug 2026Open-market sale−2.6K$89.98$237.9K
Chopra Daveen · CVP, TMTT, Surgical & IHFM26 Aug 2026Option exercise+31.8K$72.68$2.31M
Chopra Daveen · CVP, TMTT, Surgical & IHFM26 Aug 2026Open-market sale−30.6K$90.99$2.79M
Chopra Daveen · CVP, TMTT, Surgical & IHFM26 Aug 2026Open-market sale−1.2K$91.76$105.9K
Markowitz Wayne · CVP, JAPAC26 Aug 2026Open-market sale−1.2K$91.47$113.4K
Lippis Daniel J. · CVP, TAVR11 Aug 2026Option exercise+619$72.68$44.99K
Lippis Daniel J. · CVP, TAVR11 Aug 2026Open-market sale (10b5-1 plan)−619$92.03$56.97K
Markowitz Wayne · CVP, JAPAC30 Jul 2026Open-market sale−146$86.03$12.59K

Form 4 filings since 17 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

EW in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.